Efficacy and safety of LEVI-04 in patients with osteoarthritis of the knee: a randomised, double-blind, placebo-controlled, phase 2 trial

Journal:

The Lancet

Published:

2026-03-28

DOI:

10.1016/s0140-6736(26)00131-5

Affiliations:

7

Authors:

10

Go to article

Institutions	Authors	Share
Levicept, United Kingdom (UK)	5.000000	0.50
Ein Sof Innovation, United States of America (USA)	1.000000	0.10
NBCD, Denmark	1.000000	0.10
Boston University (BU), United States of America (USA)	1.000000	0.10
Prosoft Clinical, United States of America (USA)	1.000000	0.10
University of Leeds, United Kingdom (UK)	0.500000	0.05
NIHR Leeds Biomedical Research Centre, United Kingdom (UK)	0.500000	0.05

Interested in Clinical Sciences?